1. Home
  2. ADMA vs IRTC Comparison

ADMA vs IRTC Comparison

Compare ADMA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • IRTC
  • Stock Information
  • Founded
  • ADMA 2004
  • IRTC 2006
  • Country
  • ADMA United States
  • IRTC United States
  • Employees
  • ADMA N/A
  • IRTC N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • IRTC Medical/Dental Instruments
  • Sector
  • ADMA Health Care
  • IRTC Health Care
  • Exchange
  • ADMA Nasdaq
  • IRTC Nasdaq
  • Market Cap
  • ADMA 5.1B
  • IRTC 4.9B
  • IPO Year
  • ADMA N/A
  • IRTC 2016
  • Fundamental
  • Price
  • ADMA $17.80
  • IRTC $169.12
  • Analyst Decision
  • ADMA Strong Buy
  • IRTC Strong Buy
  • Analyst Count
  • ADMA 3
  • IRTC 11
  • Target Price
  • ADMA $27.67
  • IRTC $162.64
  • AVG Volume (30 Days)
  • ADMA 3.3M
  • IRTC 577.0K
  • Earning Date
  • ADMA 08-06-2025
  • IRTC 07-31-2025
  • Dividend Yield
  • ADMA N/A
  • IRTC N/A
  • EPS Growth
  • ADMA 469.09
  • IRTC N/A
  • EPS
  • ADMA 0.85
  • IRTC N/A
  • Revenue
  • ADMA $474,174,000.00
  • IRTC $657,227,000.00
  • Revenue This Year
  • ADMA $21.11
  • IRTC $25.11
  • Revenue Next Year
  • ADMA $25.97
  • IRTC $16.65
  • P/E Ratio
  • ADMA $20.93
  • IRTC N/A
  • Revenue Growth
  • ADMA 43.58
  • IRTC 22.37
  • 52 Week Low
  • ADMA $13.50
  • IRTC $55.92
  • 52 Week High
  • ADMA $25.67
  • IRTC $172.00
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 51.09
  • IRTC 66.93
  • Support Level
  • ADMA $16.93
  • IRTC $152.05
  • Resistance Level
  • ADMA $17.90
  • IRTC $168.09
  • Average True Range (ATR)
  • ADMA 0.86
  • IRTC 4.98
  • MACD
  • ADMA 0.04
  • IRTC 0.49
  • Stochastic Oscillator
  • ADMA 59.11
  • IRTC 83.13

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: